Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805437/0/en/Marker-Therapeutics-Announces-Clinical-Program-Updates-and-Pipeline-Prioritization.html

Strategic prioritization of clinical programs with focus on MT-601 in patients with lymphoma

MultiTAA-specific T cell therapies demonstrate clinical safety and positive clinical data across multiple indications

Read more at globenewswire.com

Related news for (MRKR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.